Fundraising FoxYoungheartvalve
1 known investors
Find your way into Youngheartvalve
Sign up to find every way you can get introduced to Youngheartvalve
- Your email: who you already know at Youngheartvalve, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Youngheartvalve team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
YoungHeartValve develops a tissue-free transcatheter aortic valve replacement (TAVR) technology that integrates hyaluronan into synthetic polymer leaflets to resist thrombosis and calcification. Its fully synthetic, animal-free valve platform is designed for automated, scalable manufacturing and multiple valve indications in the structural heart intervention field.
Investors · 1
Frequently asked questions
- What does Youngheartvalve do?
- YoungHeartValve develops a tissue-free transcatheter aortic valve replacement (TAVR) technology that integrates hyaluronan into synthetic polymer leaflets to resist thrombosis and calcification. Its fully synthetic, animal-free valve platform is designed for automated, scalable manufacturing and multiple valve indications in the structural heart intervention field.
- Who are Youngheartvalve's investors?
- Youngheartvalve's investors include Colorado BioScience Association.